Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.45 |
| ▸ | MALT1 | Q9UDY8 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31060035 | 0.92 | DHODH (0.41) | DHODHMALT1SMN1; SMN2NTRK1 | |
| SCHEMBL10028767 | 0.91 | DHODH (0.45) | DHODHMALT1RAB9ANTRK1NPC1 | |
| SCHEMBL29377193 | 0.91 | DHODH (0.44) | DHODHMALT1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL15984455 | 0.91 | DHODH (0.44) | DHODHMALT1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31060097 | 0.91 | DHODH (0.44) | DHODHMALT1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL29215156 | 0.90 | DHODH (0.38) | DHODHMALT1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31060047 | 0.89 | DHODH (0.40) | DHODHMALT1NTRK1GRM4MEN1 | |
| SCHEMBL13662273 | 0.89 | DHODH (0.37) | DHODHMALT1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL17238835 | 0.89 | DHODH (0.43) | DHODHMALT1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10028768 | 0.89 | DHODH (0.43) | DHODHMALT1RAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308988-A1 | Method For Controlling Diamide Resistant Pests and Compounds Therefor | SYNGENTA CROP PROTECTION AG (CH) | 2024-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240308988-A1 | Method For Controlling Diamide Resistant Pests and Compounds Therefor | DDT, NOS1, SLC11A2 | DHODH 90/4885MALT1 2427/4885RAB9A 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.